davvi36/PlasComp: Supplementary Code to CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred; v1

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: David Sünderhauf
DOI: 10.5281/zenodo.18386644
Cited by: 0

Abstract

Supplementary Code to CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred; v2

Fields of Study & Subjects

CRISPR and Genetic Engineering Bacterial Genetics and Biotechnology Evolution and Genetic Dynamics

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 January 2026